scispace - formally typeset
A

Anjan Misra

Researcher at St. Joseph's Hospital and Medical Center

Publications -  22
Citations -  4339

Anjan Misra is an academic researcher from St. Joseph's Hospital and Medical Center. The author has contributed to research in topics: Comparative genomic hybridization & Glioma. The author has an hindex of 15, co-authored 21 publications receiving 4056 citations. Previous affiliations of Anjan Misra include University of Lausanne & Barrow Neurological Institute.

Papers
More filters
Journal ArticleDOI

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

TL;DR: Previously undescribed prognostic subclasses of high-grade astrocytoma are identified and discovered to resemble stages in neurogenesis, suggesting functional relevance of tumor subtype molecular signatures is suggested by the ability of cell line signatures to predict neurosphere growth.
Journal ArticleDOI

Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma

TL;DR: The results indicate that integrating DNA and mRNA-based tumor profiles offers the potential for a clinically relevant classification more robust than either method alone and provides a basis for identifying genes important in glioma pathogenesis.
Journal ArticleDOI

Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors.

TL;DR: The results show that most aberrant methylation events are focal and independent of deletions, and the rare convergence of these mechanisms can pinpoint biallelic gene inactivation without the use of positional cloning.
Journal ArticleDOI

Identification of IGF2 signaling through phosphoinositide-3-kinase regulatory subunit 3 as a growth-promoting axis in glioblastoma.

TL;DR: Evidence is provided that the IGF2–PIK3R3 signaling axis is involved in promoting the growth of a subclass of highly aggressive human GBMs that lack EGF receptor amplification and the importance of the phosphoinositide 3-kinase/Akt pathway for growth of high-grade gliomas is underscored.